Metabolomics,Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

Simvastatin treated Lymphoblastoid Cell lines from Cholesterol and Pharmacogenomics (CAP) Trial


ABSTRACT: Statins reduce cardiovascular disease risk by lowering plasma low density lipoprotein (LDL)-cholesterol. To identify novel pathways that modulate statin response, we assessed the influence of simvastatin exposure on expression quantitative trait locus (eQTL) associations across the genome in 480 lymphoblastoid cell lines (LCLs). Cell lines were derived blood samples collected ant entry visit from participants in the Cholesterol and Pharmacogenomics (CAP) trial, who underwent a 6 week 40mg/day simvastatin trial. We identified 4590 cis-eQTLS that were independent of treatment status (FDR=1%) and six cis-eQTLS for which there was evidence of an interaction with treatment (FDR=20%). Genotypes and Phenotypes derived from these indivudals are available through dbGaP (Accession Number). eQTL results are available at: http://eqtl.uchicago.edu/cgi=bin/gbrowse/eqtl/ Dataset consists of 960 expression beadarrays (Illumina HumanRef-8v3) representing paired samples derived from 24-hour exposures of 480 lymphoblastoid cell lines (LCLs) to 2 micromolar simvastatin acid or control buffer.

ORGANISM(S): Homo sapiens

SUBMITTER: Lara Mangravite 

PROVIDER: E-GEOD-36868 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

Similar Datasets

2011-12-01 | E-GEOD-25942 | biostudies-arrayexpress
2012-03-21 | E-MTAB-832 | biostudies-arrayexpress
2010-10-08 | E-GEOD-24583 | biostudies-arrayexpress
2011-10-02 | E-GEOD-32492 | biostudies-arrayexpress
2011-04-19 | E-GEOD-15779 | biostudies-arrayexpress
2011-01-20 | E-GEOD-26683 | biostudies-arrayexpress
2016-02-29 | PXD002640 | Pride
2011-07-31 | E-GEOD-29775 | biostudies-arrayexpress
2012-07-31 | E-GEOD-31450 | biostudies-arrayexpress
2011-10-24 | E-GEOD-28356 | biostudies-arrayexpress